Provided by Tiger Trade Technology Pte. Ltd.

Fennec Pharmaceuticals Inc.

5.91
-0.6000-9.22%
Post-market: 5.910.00000.00%16:10 EDT
Volume:203.48K
Turnover:1.23M
Market Cap:201.85M
PE:-16.73
High:6.54
Open:6.46
Low:5.91
Close:6.51
52wk High:9.92
52wk Low:4.68
Shares:34.15M
Float Shares:22.75M
Volume Ratio:0.42
T/O Rate:0.89%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3534
EPS(LYR):-0.3534
ROE:-69.06%
ROA:-7.32%
PB:5.75
PE(LYR):-16.73

Loading ...

Tampa General Hospital Cancer Institute Launches Real-World Study of Fennec’s PEDMARK in Cisplatin Patients

Reuters
·
Mar 04

Fennec Pharmaceuticals Director Rosty Raykov Disposes of Common Shares

Reuters
·
Mar 04

Analysts Have Conflicting Sentiments on These Healthcare Companies: Bausch Health Companies (BHC), Fennec Pharmaceuticals (FENC) and InfuSystem Holdings (INFU)

TIPRANKS
·
Feb 20

Fennec Pharmaceuticals reports real-world data supporting PEDMARK use after cisplatin in adult head and neck cancer patients

Reuters
·
Feb 20

Fennec initiated with a Buy at B. Riley

TIPRANKS
·
Feb 12

U.S. RESEARCH ROUNDUP-Equinix, Generac, Gilead

Reuters
·
Feb 12

Fennec Pharmaceuticals Inc : B. Riley Initiates Coverage With Buy Rating; Target Price $16.00

THOMSON REUTERS
·
Feb 12

Fennec Pharmaceuticals Director Rosty Raykov Reports Disposal of Common Shares

Reuters
·
Feb 03

Piper Sandler Initiates Fennec Pharmaceuticals at Overweight

MT Newswires Live
·
Jan 09

Fennec Pharmaceuticals Inc : Piper Sandler Initiates Coverage With Overweight Rating; Target Price $18

THOMSON REUTERS
·
Jan 09

Fennec initiated with an Overweight at Piper Sandler

TIPRANKS
·
Jan 09

Southpoint Capital Advisors Reports Sale of Fennec Pharmaceuticals Common Shares

Reuters
·
Dec 30, 2025

Southpoint Capital Advisors- Southpoint Controls 2.7 Mln Common Shares, 8% of Outstanding Common Shares of Fennec

THOMSON REUTERS
·
Dec 27, 2025

Southpoint holdings in Fennec Pharmaceuticals Inc. (TSX: FENC)

GlobeNewswire
·
Dec 27, 2025

Fennec Pharmaceuticals Inc - Study to Evaluate Pedmark for Preventing Cisplatin-Induced Ototoxicity

THOMSON REUTERS
·
Dec 09, 2025

Fennec Pharmaceuticals Announces Investigator-Sponsored Trial to Be Conducted by City of Hope in Metastatic Testicular Germ Cell Tumors

GlobeNewswire
·
Dec 09, 2025

Director Rosty Raykov Reports Sale of Fennec Pharmaceuticals Inc. Common Shares

Reuters
·
Dec 06, 2025

BRIEF-Fennec Pharmaceuticals Announces Positive Topline Results

Reuters
·
Dec 02, 2025

Fennec Pharmaceuticals Reports Positive Results for PEDMARK in Japanese Pediatric Cancer Study

Reuters
·
Dec 02, 2025

Fennec Pharmaceuticals Inc - Plans to Pursue Registration for Pedmark in Japan

THOMSON REUTERS
·
Dec 02, 2025